Comparing Medifast

Comparing Medifast


Medifast and Simply Good Foods are both small-cap special foods & welbeing products companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings. Medifast presently has a consensus target price of $72.00, suggesting a potential upside of 7.95%.



from Biotech News